Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Xiaolin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3422-9949; OpenAlex author ID A5100642001. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 7

  1. Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.intimp.2024.111590↗
  2. An iodine-125 seed strand combined with a metal stent versus a metal stent alone for obstructive jaundice caused by pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.brachy.2020.10.004↗
  3. Chemotherapy response of pancreatic cancer by diffusion-weighted imaging (DWI) and intravoxel incoherent motion DWI (IVIM-DWI) in an orthotopic mouse model. Last author DOI 10.1007/s10334-019-00745-3↗
  4. Lactic dehydrogenase to albumin ratio in prediction of unresectable pancreatic cancer with intervention chemotherapy. Last author DOI 10.2217/fon-2017-0556↗
  5. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. Co-author DOI 10.7150/jca.23989↗
  6. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Last author DOI 10.1158/1940-6207.capr-12-0307↗
  7. Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies. Co-author DOI 10.1007/s10552-011-9856-y↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Chen · 1 shared paper, 2024 · strength 0.28
  2. G Li · 1 shared paper, 2024 · strength 0.28
  3. Yangyang Lei · 1 shared paper, 2024 · strength 0.28
  4. Junhao Li · 3 shared papers, 2018–2021 · strength 0.26
  5. Yi Chen · 3 shared papers, 2013–2021 · strength 0.23
  6. Shanshan Gao · 2 shared papers, 2018–2021 · strength 0.19
  7. Guofeng Zhou · 2 shared papers, 2018 · strength 0.15
  8. Wenhui Lou · 2 shared papers, 2018 · strength 0.15
  9. Li Wu · 1 shared paper, 2019 · strength 0.12
  10. Jing Li · 1 shared paper, 2019 · strength 0.12
  11. Ning Pu · 1 shared paper, 2021 · strength 0.11
  12. Minjie Yang · 1 shared paper, 2021 · strength 0.11
  13. Li Zhang · 1 shared paper, 2021 · strength 0.11
  14. Yi Chen · 1 shared paper, 2018 · strength 0.08
  15. Tianzhu Yu · 1 shared paper, 2018 · strength 0.08
  16. Xiaoyu Liu · 1 shared paper, 2018 · strength 0.07
  17. Wansheng Wang · 1 shared paper, 2013 · strength 0.04
  18. Dayong Jin · 1 shared paper, 2013 · strength 0.04
  19. Quan Hongbo · 1 shared paper, 2012 · strength 0.03
  20. Jian Wang · 1 shared paper, 2012 · strength 0.03
  21. Gen-lai Lin · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.